# KLRS (Kalaris Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Kalaris Therapeutics, Inc. reported $89.00M in total assets and a net loss of $43.40M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/KLRS
- Markdown: https://convexityos.com/fundamentals/KLRS.md
- SEC CIK: 0001754068
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:53 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001754068&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$46.83M | Operating profit |
| Net Income | FY 2025 | -$43.40M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.82 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$38.57M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $82.86M | Total debt: $1.33M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | $165K |
| Research & Development | $30.75M | $45.04M | $133.1M | $118.9M | $120.7M | $49.66M | $16.25M |
| Total Operating Expenses | $46.15M | $51.73M | $199.9M | $171.2M | $169.8M | $71.31M | $26.87M |
| **Operating Income** | -$46.15M | -$51.73M | -$199.9M | -$171.2M | -$169.8M | -$71.31M | -$26.70M |
| **EBITDA** | -$46.14M | -- | -$199.5M | -$170.5M | -$169.6M | -$71.24M | -$26.68M |
| Interest Income | -- | $5.49M | $5.73M | $1.88M | $1.31M | $1.33M | $2.06M |
| Interest Expense | $1.44M | $2.70M | -- | -- | -- | -- | -- |
| Income Before Tax | -$43.44M | -$69.17M | -$190.5M | -$169.0M | -$171.0M | -$69.78M | -$23.84M |
| Income Tax Expense | $0 | $0 | -$126K | -$265K | $1.01M | -- | -- |
| **Net Income** | -$43.44M | -$69.17M | -$190.4M | -$168.7M | -$172.0M | -$69.78M | -$23.84M |
| Basic EPS | -$2.85 | -$51.77 | -$3,660.00 | -$4,397.80 | -$5,477.26 | -$5,177.41 | -$37,061.47 |
| **Diluted EPS** | -$2.85 | -$51.77 | -$3,660.00 | -$4,397.80 | -$5,477.26 | -$5,177.41 | -$37,061.47 |
| Basic Shares Outstanding | 15.3M | 1.3M | 52.0K | 38.3K | 31.4K | 13.5K | 643 |
| Diluted Shares Outstanding | 15.3M | 1.3M | 52.0K | 38.3K | 31.4K | 13.5K | 643 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $8.34M | $9.02M | $7.57M | $7.16M | $9.13M | $8.44M | $6.03M | $3.85M |
| Total Operating Expenses | $11.81M | $12.39M | $11.83M | $10.80M | $12.74M | $12.26M | $10.35M | $7.13M |
| **Operating Income** | -$11.81M | -$12.39M | -$11.83M | -$10.80M | -$12.74M | -$12.26M | -$10.35M | -$7.13M |
| **EBITDA** | -$11.80M | -$12.38M | -$11.82M | -- | -- | -- | -- | -- |
| Interest Income | -- | -- | -- | -- | -- | -- | -- | $1.39M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $1.44M | $1.31M |
| **Net Income** | -$11.03M | -$11.52M | -$10.86M | -$10.00M | -$11.89M | -$11.35M | -$10.20M | -$22.03M |
| Basic EPS | -$0.46 | -$0.48 | -$0.46 | -- | -$0.64 | -$0.61 | -$2.52 | -- |
| **Diluted EPS** | -$0.46 | -$0.48 | -$0.46 | -- | -$0.64 | -$0.61 | -$2.52 | -- |
| Basic Shares Outstanding | 23.8M | 23.8M | 23.7M | -- | 18.7M | 18.7M | 4.1M | -- |
| Diluted Shares Outstanding | 23.8M | 23.8M | 23.7M | -- | 18.7M | 18.7M | 4.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $98.05M | $1.64M | $90.12M | $106.1M | $201.7M | $122.7M | $61.08M |
| Short-Term Investments | $19.93M | $0 | $93.82M | $127.7M | $46.46M | $233.7M | $64.99M |
| **Cash & Short-Term Investments** | $118.0M | $118.3M | $183.9M | $233.8M | $248.1M | $356.3M | $126.1M |
| **Total Current Assets** | $118.8M | $2.61M | $187.6M | $243.1M | $253.3M | $361.3M | $127.3M |
| Property, Plant & Equipment, Net | -- | -- | -- | $930K | $1.55M | $812K | $350K |
| Long-Term Investments | $0 | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $953K | $410K | $122K | $612K | $1.10M | -- | -- |
| **Total Non-Current Assets** | $2.93M | $3.56M | $3.16M | $34.03M | $33.25M | $9.50M | $12.11M |
| **Total Assets** | $121.7M | $6.16M | $190.8M | $277.1M | $286.6M | $370.8M | $139.4M |
| Accounts Payable | $1.28M | $1.56M | $6.76M | $3.00M | $8.36M | $963K | $630K |
| Other Current Liabilities | -- | $22K | $739K | -- | -- | -- | -- |
| **Total Current Liabilities** | $9.71M | $24.70M | $28.37M | $24.34M | $37.85M | $12.29M | $9.11M |
| **Total Non-Current Liabilities** | $33.21M | $32.08M | $16.65M | $28.22M | $23.48M | $5.46M | $8.69M |
| **Total Liabilities** | $42.92M | $56.78M | $45.02M | $52.56M | $61.33M | $17.76M | $17.80M |
| **Total Debt (incl. Leases)** | $1.45M | -- | $27.43M | $35.39M | $30.07M | $8.69M | $11.76M |
| Common Stock | $2.0K | $0 | $0 | $9.0K | $7.0K | $7.0K | -- |
| Retained Earnings | -$160.0M | -$116.6M | -$656.2M | -$465.8M | -$297.1M | -$125.1M | -$55.32M |
| Accumulated Other Comp. Income | $6.0K | $0 | -$62K | -$468K | -$155K | -$112K | $68K |
| **Total Stockholders' Equity** | $78.81M | -$96.62M | -$45.02M | $224.5M | $225.3M | $353.1M | -$51.50M |
| Total Equity | $78.81M | -$96.62M | -$45.02M | $224.5M | $225.3M | $353.1M | -$51.50M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $47.38M | $43.17M | $34.43M | $98.05M | $42.39M | $88.43M | $101.0M | $1.64M |
| Short-Term Investments | $35.47M | $50.37M | $62.79M | $19.93M | $34.61M | -- | -- | $0 |
| **Cash & Short-Term Investments** | $82.90M | $93.50M | $104.9M | $118.0M | $77K | $88.43M | $101.0M | $118.3M |
| **Total Current Assets** | $85.18M | $95.92M | $98.47M | $118.8M | $78.18M | $91.65M | $102.2M | $2.61M |
| Long-Term Investments | -- | -- | $7.65M | $0 | -- | -- | -- | -- |
| Other Non-Current Assets | $1.98M | $1.73M | $1.75M | $953K | $976K | $691K | $410K | $410K |
| **Total Non-Current Assets** | $3.83M | $3.62M | $11.34M | $2.93M | $2.99M | $1.19M | $910K | $3.56M |
| **Total Assets** | $89.00M | $99.54M | $109.8M | $121.7M | $81.17M | $92.84M | $103.1M | $6.16M |
| Accounts Payable | $2.75M | $1.12M | $905K | $1.28M | $494K | $3.68M | $2.37M | $1.56M |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | $230K | $22K |
| **Total Current Liabilities** | $8.51M | $8.74M | $8.08M | $9.71M | $6.07M | $7.65M | $7.14M | $24.70M |
| **Total Non-Current Liabilities** | $33.09M | $33.13M | $33.17M | $33.21M | $33.24M | $32.08M | $32.08M | $32.08M |
| **Total Liabilities** | $41.60M | $41.87M | $41.25M | $42.92M | $39.31M | $39.73M | $39.22M | $56.78M |
| **Total Debt (incl. Leases)** | $1.33M | $1.40M | $1.41M | $1.45M | $1.54M | -- | -- | -- |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $0 |
| Retained Earnings | -$193.4M | -$182.4M | -$170.9M | -$160.0M | -$150.0M | -$138.1M | -$126.8M | -$116.6M |
| Accumulated Other Comp. Income | -$69K | -$73K | -$49K | $6.0K | $6.0K | -- | -- | $0 |
| **Total Stockholders' Equity** | $47.40M | $57.67M | $68.56M | $78.81M | $41.87M | $53.12M | $63.87M | -$96.62M |
| Total Equity | $47.40M | $57.67M | $68.56M | $78.81M | $41.87M | $53.12M | $63.87M | -$96.62M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$43.44M | -$69.17M | -$190.4M | -$168.7M | -$172.0M | -$69.78M | -$23.84M |
| Depreciation & Amortization | $13K | -- | $398K | $723K | $189K | $73K | $19K |
| Stock-Based Compensation | $1.94M | $895K | $40.78M | $41.31M | $43.98M | $9.43M | $2.89M |
| Change in Payables | -$88K | -$1.03M | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$38.37M | -$20.67M | -$124.5M | -$142.1M | -$106.3M | -$60.81M | -$20.16M |
| Capital Expenditure | -$200K | -- | -- | -- | -$26K | -$235K | -$339K |
| **Free Cash Flow** | -$38.57M | -- | -- | -- | -$106.3M | -$61.05M | -$20.49M |
| Purchases of Investments | -$34.52M | -- | -$125.8M | -$228.8M | -$76.59M | -$300.3M | -$119.3M |
| **Investing Cash Flow** | -$19.72M | $95.00M | $37.98M | -$80.48M | $186.0M | -$169.5M | -$64.64M |
| Common Stock Issued | $42.00M | -- | -- | $126.4M | -- | -- | -- |
| **Financing Cash Flow** | $155.0M | $19.14M | $70.50M | $127.0M | $232K | $292.0M | $120.9M |
| **Net Change in Cash** | $96.91M | -$1.53M | -$15.97M | -$95.57M | $79.85M | $61.58M | $36.12M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$11.03M | -$11.52M | -$10.86M | -$10.00M | -$11.89M | -$11.35M | -$10.20M | -$22.03M |
| Depreciation & Amortization | $10K | $10K | $10K | -- | -- | -- | -- | -- |
| Stock-Based Compensation | $752K | $644K | $580K | $333K | $638K | $591K | $374K | $280K |
| Change in Payables | $1.71M | $144K | -$376K | $874K | -$3.20M | $1.31M | $934K | -$898K |
| **Operating Cash Flow** | -$10.55M | -$11.05M | -$11.58M | -$7.06M | -$11.33M | -$12.54M | -$7.44M | -$7.85M |
| Purchases of Investments | -$159K | $169K | -$70.35M | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $14.84M | $20.17M | -$50.35M | -- | -- | -- | -- | $5.00M |
| **Financing Cash Flow** | -$75K | -$377K | -$1.70M | $47.74M | $0 | $0 | $107.3M | $7.58M |
| **Net Change in Cash** | $4.21M | $8.75M | -$63.63M | $55.67M | -$46.04M | -$12.54M | $99.83M | -$274K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -16182.4% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -14447.9% |
| Return on Equity (ROE) | -55.1% | -- | -- | -75.1% | -76.3% | -19.8% | -- |
| Return on Assets (ROA) | -35.7% | -1122.5% | -99.8% | -60.9% | -60.0% | -18.8% | -17.1% |
| Current Ratio | 12.23x | 0.11x | 6.61x | 9.99x | 6.69x | 29.39x | 13.98x |
| Quick Ratio | 12.15x | 4.79x | 6.48x | 9.61x | 6.55x | 28.98x | 13.85x |
| Debt to Equity | 0.02x | -- | -- | 0.16x | 0.13x | 0.02x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -91.5% | -76.7% | -64.3% | -55.1% | -132.5% | -153.7% | -118.9% | -- |
| Return on Assets (ROA) | -48.8% | -44.5% | -40.2% | -35.7% | -68.3% | -88.0% | -73.7% | -1122.5% |
| Current Ratio | 10.00x | 10.98x | 12.19x | 12.23x | 12.89x | 11.98x | 14.31x | 0.11x |
| Quick Ratio | 9.74x | 10.70x | 12.98x | 12.15x | 0.01x | 11.56x | 14.14x | 4.79x |
| Debt to Equity | 0.03x | 0.02x | 0.02x | 0.02x | 0.04x | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
